Moderna
MRNA
#270
Rank
ยฃ67.87 B
Marketcap
ยฃ170.02
Share price
14.21%
Change (1 day)
746.23%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -ยฃ2.29 Billion

According to Moderna 's latest financial reports the company's current earnings are ยฃ2.21 Billion. In 2025 the company made an earning of -ยฃ2.09 Billion, an increase over its 2024 earnings that were of -ยฃ2.71 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ2.29 Billion9.73%
2025 -ยฃ2.09 Billion-23.03%
2024 -ยฃ2.71 Billion-8.22%
2023 -ยฃ2.96 Billion-140.65%
2022 ยฃ7.25 B-27.81%
2021 ยฃ10.05 B-1911.15%
2020 -ยฃ0.56 Billion44.7%
2019 -ยฃ0.39 Billion28.63%
2018 -ยฃ0.3 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.80 B-960.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ11.72 B-609.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ5.81 B-352.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-ยฃ35.84 Million-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ88.91 Million-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ31.56 Million-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.84 B-136.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-ยฃ0.13 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA